✦ LIBER ✦

Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target

✍ Scribed by Jembrek, Maja Jazvinšćak; Babić, Mirjana; Pivac, Nela; Hof, Patrick R.; Šimić, Goran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening of treatment targets for Alzhe

✍ Lian-Feng Lin; Huan-Min Luo 📂 Article 📅 2011 🏛 Shanghai Institutes for Biological Sciences, Chine 🌐 English ⚖ 755 KB

CHF5074 reduces brain β-amyloid burden a

✍ Pizzi, M.; Lanzillotta, A.; Imbimbo, B.P.; Hutter-Paier, B.; Villetti, G.; Facch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P3-028 The CSF Aβ42, Tau and phosphoryla

✍ Herukka, Sanna-Kaisa; Helisalmi, Seppo; Tervo, Susanna; Hallikainen, Merja; Vanh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Transgenic mouse models for Alzheimer's

✍ Muyllaert, D.; Terwel, D.; Borghgraef, P.; Devijver, H.; Dewachter, I.; Van Leuv 📂 Article 📅 2006 🏛 Masson Editeur 🌐 English ⚖ 206 KB

Current advances in the treatment of Alz

✍ Yang Hong-Qi, Sun Zhi-Kun, Chen Sheng-Di 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 283 KB

NPT001: A candidate therapeutic for clea

✍ Fisher, Richard; Gannon, Kimberley; Krishnan, Rajaraman; Tsubery, Haim; Masliah, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB